Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

By sjmartinez • May 18, 2025

Oprea AD, Ostapenko LJ, Sweitzer B, Selzer A, Irizarry-Alvarado JM, Hurtado Andrade MD, Mendez CE, Kelley KD, Stewart E, Fernandez Robles CR, Chadha RM, Camilleri M, Mathur R, Umpierrez GE, Hepner DL. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025 May 15:S0007-0912(25)00214-4. doi: 10.1016/j.bja.2025.04.001. Epub ahead of print. PMID: 40379536.

Tags: Cedars Sinai DoM, diabetes mellitus, Endocrinology, gastric emptying, glucagon-like peptide 1 receptor agonists, major adverse cardiovascular events, Obesity, perioperative care, Publications

South Asian Cardiovascular Risk: Role of Coronary Artery Calcium Scoring and Computed Tomography Angiography

Kalra DK, Vedamurthy D, Hosadurg N, Goyal A, Gupta M, Pagidipati N, Slipczuk L, Dey D, Mehta A, Joshi P, Baskaran L, Wong N, Virani[...]

Short-interval coronary plaque remodeling assessed by serial AI-quantified coronary CTA during intensive plaque-directed therapy

Karlsberg RP, Thummala AR, Elisarraras FX, Golub IS, Cho GW. Short-interval coronary plaque remodeling assessed by serial AI-quantified coronary CTA during intensive plaque-directed therapy. J[...]

A National Institute on Aging workshop on sex differences in health across the lifespan

Pea J, Addie S, Ambrosio F, Anderson RM, Bairey Merz CN, Barr E, Carrington-Lawrence S, de Cabo R, Desvigne-Nickens P, Dubal DB, Haakenson C, Hargove-Grimes[...]